Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Vos

Showing results (51-60 of 304) with videos related to

Pageof 31
Sort By:
BMC Psychiatry|August 24, 2010
Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in ThailandBenjamas Prukkanone, Theo Vos, Philip Burgess, et al.
Population Health Metrics|August 18, 2010
Schizophrenia in Thailand: prevalence and burden of diseasePudtan Phanthunane, Theo Vos, Harvey Whiteford, et al.
The Australian and New Zealand Journal of Psychiatry|January 22, 2005
Assessing cost-effectiveness of drug interventions for schizophreniaAnne Magnus, Vaughan Carr, Cathrine Mihalopoulos, et al.
International Journal of Epidemiology|December 3, 2008
Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gapTheo Vos, Bridget Barker, Stephen Begg, et al.
Tobacco Control|July 27, 2007
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in AustraliaMelanie Y Bertram, Stephen S Lim, Angela L Wallace, et al.
Health Promotion International|June 18, 2011
Future predictions of body mass index and overweight prevalence in Australia, 2005-2025Michelle M Haby, Alison Markwick, Anna Peeters, et al.
Bulletin of the World Health Organization|March 17, 2012
Prioritizing risk factors to identify preventive interventions for economic assessmentNick Wilson, Tony Blakely, Rachel H Foster, et al.
The Australian and New Zealand Journal of Psychiatry|August 10, 2004
Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorderMarie Donnelly, Michelle M Haby, Rob Carter, et al.
The Australian and New Zealand Journal of Psychiatry|July 30, 2005
Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depressionTheo Vos, Justine Corry, Michelle M Haby, et al.
Plos One|June 1, 2013
Evaluating the quality of national mortality statistics from civil registration in South Africa, 1997-2007Jané Joubert, Chalapati Rao, Debbie Bradshaw, et al.
Pageof 31

Showing results (51-60 of 304) with videos related to

Sort By:
Pageof 31
BMC Psychiatry|August 24, 2010
Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in ThailandBenjamas Prukkanone, Theo Vos, Philip Burgess, et al.
Population Health Metrics|August 18, 2010
Schizophrenia in Thailand: prevalence and burden of diseasePudtan Phanthunane, Theo Vos, Harvey Whiteford, et al.
The Australian and New Zealand Journal of Psychiatry|January 22, 2005
Assessing cost-effectiveness of drug interventions for schizophreniaAnne Magnus, Vaughan Carr, Cathrine Mihalopoulos, et al.
International Journal of Epidemiology|December 3, 2008
Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gapTheo Vos, Bridget Barker, Stephen Begg, et al.
Tobacco Control|July 27, 2007
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in AustraliaMelanie Y Bertram, Stephen S Lim, Angela L Wallace, et al.
Health Promotion International|June 18, 2011
Future predictions of body mass index and overweight prevalence in Australia, 2005-2025Michelle M Haby, Alison Markwick, Anna Peeters, et al.
Bulletin of the World Health Organization|March 17, 2012
Prioritizing risk factors to identify preventive interventions for economic assessmentNick Wilson, Tony Blakely, Rachel H Foster, et al.
The Australian and New Zealand Journal of Psychiatry|August 10, 2004
Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorderMarie Donnelly, Michelle M Haby, Rob Carter, et al.
The Australian and New Zealand Journal of Psychiatry|July 30, 2005
Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depressionTheo Vos, Justine Corry, Michelle M Haby, et al.
Plos One|June 1, 2013
Evaluating the quality of national mortality statistics from civil registration in South Africa, 1997-2007Jané Joubert, Chalapati Rao, Debbie Bradshaw, et al.
Pageof 31